More evidence continues to surface that shows that Ivermectin is both safe and effective in treating Covid-19.
In a meta-analysis that includes dozens of studies examining the effectiveness of Ivermectin in treating Covid-19, 100% of studies found that using Ivermectin as a treatment yielded positive results.
The studies found that Ivermectin was both safe for use in proper doses and effective in reducing mortality for Covid-19 patients.
Still, medical professionals are being ridiculed and in some cases risk losing their jobs for prescribing patients Ivermectin as a Covid-19 treatment.
The FDA and state governments have continued to ignore mounting evidence proving the effectiveness of Ivermectin, meaning that there are doctors who are being investigated by their state medical boards for prescribing Ivermectin.
In some cases, medical professionals have claimed that they are being sent threatening notices/letters from prosecuting authorities in states such as New York.
The Epoch Times Reports–
So we now know that ivermectin and vitamin D is safe and effective against covid.
Why was this censored and surpressed by the so called experts?
— PeterSweden (@PeterSweden7) December 30, 2022
In a meta-analysis of 63 studies of ivermectin versus COVID-19 in humans, 100% of these have shown positive results. Studies were from all continents except Antarctica. Considered individually, 29 of those studies were found to be statistically significant regarding use of ivermectin alone. Over the 63 studies in meta-analysis, pooled effects showed 69% improvement in early treatment, and prophylactic use showed 86% improvement. Of those studies in the meta-analysis that were peer-reviewed, overall improvement in early treatment was found to be 70% (64% in randomized controlled trials), and 86% of those in which ivermectin was used prophylactically showed improvement (84% in randomized controlled trials).
Mortality from COVID-19 over all time periods of delay in treatment was 76% improved over controls (69% in randomized controlled trials), whereas mortality was improved 84% in early treatment of COVID-19 (82% in randomized controlled trials). Forty studies were excluded from the meta-analysis for complicating factors or insufficient detail reported, and these also showed 100% positive results.